Free radical generation and the role of allopurinol as a cardioprotective agent during coronary artery bypass grafting surgery

Canadian Journal of Cardiology

Volumn 12, Issue 2, 1996, Pages 138-144

  Movahed, Ali ^a   Nair, K G ^a,b   Ashavaid, T F ^a   Kumar, Pavan ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

^b BREACH CANDY HOSPITAL   (India)

Author keywords

Allopurinol; Cardioprotection; Free radicals; Reperfusion

Indexed keywords

ALLOPURINOL; CREATINE KINASE; CREATINE KINASE MB; FREE RADICAL; MALONALDEHYDE; PYRAZOLOPYRIMIDINE DERIVATIVE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATINE KINASE BLOOD LEVEL; DISEASE SEVERITY; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; LIPID PEROXIDATION; MALE; ORAL DRUG ADMINISTRATION; SPECTROPHOTOMETRY; TIME;

ALLOPURINOL; ANTIMETABOLITES; CORONARY ARTERY BYPASS; CREATINE KINASE; FEMALE; FREE RADICALS; HUMANS; ISOENZYMES; LIPID PEROXIDATION; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0029967550     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Hearse DJ. Reperfusion of the ischemic myocardium. J Mol Cell Cardiol 1977;9:605-6.
2. Braunwald E, Kloner RA. Myocardial reperfusion: a double edged sword? J Clin Invest 1985;76:1713-9.
3. Opie LH. Reperfusion injury and its pharmacologic modification. Circulation 1989;80:1049-62.
4. Weisfeldt ML. Reperfusion and reperfusion injury. Clin Res 1987;35:13-20.
5. Kloner RA. Does reperfusion injury exist in humans? J Am Coll Cardiol 1993;21:537-45.
6. Simpson PJ, Lucchesi BR. Free radicals and myocardial ischemia and reperfusion injury. J Lab Clin Med 1987;110:13-30.
7. Bolli R. Oxygen-derived free radicals and post-ischemic myocardial dysfunction ('stunned myocardium'). J Am Coll Cardiol 1988;12:239-49.
8. Ferrari R, Cecorti C, Curello C, et al. Oxygen free radicals and myocardial damage, protective role of thio- containing agents. Am J Med 1991;91:955-1045.
9. McCord JM. Are free radicals a major culprit? In: Hearse DJ, Yellon DN, eds. Therapeutic Approaches to Myocardial Infarct Size Limitation. New York: Raven Press, 1984:209-18.
10. Jennings RB, Reimer KA, Hill ML, Mayer SE. Total ischemia in dog hearts in vitro. Circ Res 1981;49:892-904.
11. Roy RS, McCord JM. Superoxide and ischemia. In: Greenwald R, Cohen G, eds. O Radicals and their Scavenger Systems, vol 2. Cellular and Molecular Aspects. New York: Elsevier Science, 1983:145-53.
12. Coghlan JG, Flitter WD, Glutton SM, et al. Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994;107:248-56.
13. Chambers DJ, Braimbridge MV, Hearse DJ. Free radical and cardioplegia: allopurinol and oxypurinol reduce myocardial injury following ischemic arrest. Ann Thorac Surg 1987;44:291-7.
14. Reimer KA, Jennings RB. Failure of xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs. Circulation 1985;71:1069-75.
15. Podzuweit T, Muller A, Beck H, Scheld HH, Schaper W. Absence of xanthine oxidoreductase activity in human myocardium. Adv Exp Med Biol 1991;309A:353-6.
16. Manciet LH, Copeland JG. Lipid peroxidation results in compromised functional recovery of isolated rabbit hearts after low-pressure, hypothermic, perfused preservation for 24 hours. J Thorac Cardiovasc Surg 1992;103:532-40.
17. Rodkey FL. Standard method for albumin determination. Clin Chem 1964;10:606-7.
18. Rosalki S. Kinetic method of estimation of CK-MB. J Lab Clin Med 1967;69:696.
19. Alpert NL. Instrument Series: Report No14, Glucose Analyser and BUN Analyzer. Lab World 1973;24:40.
20. Bolli R, Bharat SP, Mohamed OJ, Edward KL, Paul BM. Demonstration of free radical generation in stunned myocardium of intact dogs with the use of spin trap α-phenyl-tert-butyl-nitrone. J Clin Invest 1988;82:476-85.
21. Das R, Prabhananda BS. Magnetic anisotropy of cupric complexes from ESR in solution: use of mixed ligand complexes. J Magn Reson 1933;54:89.
22. Mergner GW, Weglicki WB, Kramer JH. Postischemic free radical production in the venous blood cardioplegia without right heart isolation. Eur J Cardiothorac Surg 1990;4:163-7.
23. Tortolani AJ, Powell SR, Vladimir M, William BW, Gustave JP, Kramer JH. Detection of alkoxyl and carbon- centered free radicals during bypass surgery. Free Radic Biol Med 1993;14:421-6.
24. Arroyo CM, Kramer JH, Luboff RH, Mergner GW, Dickens BF, Weglicki WB. Spin trapping of oxygen and carbon centred free radicals in ischemic canine myocardium. Free Radic Biol Med 1988;5:313-6.
25. Jayakumari N, Jayakumari NK, Sunitha KV, et al. Enhanced lipid peroxidation in patients during coronary artery bypass grafting. Indian Heart J 1983;45:489-91.
26. Davies SW, Duffy JP, Wickens DG, et al. Time course of free radical activity during coronary artery operations with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;105:979-87.
27. Prasad K, Kastra J, Bharadwaj B, Chaudhary AK. Increased oxygen free radical activity in patients on cardiopulmonary bypass undergoing aortocoronary bypass surgery. Am Heart J 1992;123:37.
28. Murrell GAC, Rapeport WG. Clinical pharmacokinetics of allopurinol. Clin Pharmacokinet 1986;11:343-53.
29. Johnson W, Kayser K, Brenowitz J, Saedi S. A randomised control trial of allopurinol in coronary bypass surgery. Am Heart J 1991;121:22-4.
30. Grum GM, Gallagher KP, Kirsh MM, Shlafer M. Absence of detectable xanthine oxidase in human myocardium. J Mol Cell Cardiol 1989;21:263-72.
31. Eddy LJ, Stewart JR, Jones HP, Engerson TD, McCord JM, Downey JM. Free radical producing enzyme, xanthine oxidase, is undetectable in human hearts. Am J Physiol 1987;253:H709.
32. Lunec J. Oxygen radicals: their measurement and role in major disease. J Int Fed Clin Chem 1992;4:60.
33. Fridovich I. The Biology of Oxygen Radicals Threats and Defence: Oxygen Radicals in the Pathophysiology of Heart Disease, 1st edn. Boston: Kluwer, 1988.
34. Grech ED, Dodd NJF, Bellamy CM, Perry RA, Momson WL, Ramsdale DR. Free radical generation during angioplasty. Lancet 1993;341:990-1.
35. McCord JM. Oxygen derived free radicals in post-ischemic tissue injury. N Engl J Med 1985;312:159-63.
36. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994;15:7-10.
37. Rashid HA, Williamolosson G. Influence of allopurinol on cardiac complications in open heart operations. Ann Thorac Surg 1991;52:127-30.
38. Dewall RA, Vasko KA, Stanley EL, Kezdi P. Response of the ischemic myocardium to allopurinol. Am Heart J 1971;82:362-70.
39. Downey MJ, Hearse DJ, Yellon MD. The role of xanthine oxidase during myocardial ischemia in several species including man. J Mol Cell Cardiol 1988;20:55-63.
40. Ellis CH, Touw KB, Dickerson SW. Some acute hemodynamic effects of large doses of sodium allopurinol in open chested dogs. Arch Int Pharmacodyn Ther 1973;205:355-61.
41. Arnold WL, DeWall R, Kezdi P, Zwart H. The effect of allopurinol on the degree of early myocardial ischemia. Am Heart J 1980;99:614-24.